Management of Acute Stroke Patients on Treatment with New Oral Anticoagulants: Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry

Brief description of study

The purpose of this study is to improve the treatment and management of patients with either AIS (Acute Ischemic Stroke) or ICH (Intracranial Hemorrhage) on anticoagulant therapy. We are looking to enroll patients who have recently been admitted to the hospital to receive treatment for your stroke. The total duration of participation in this study will be about 12 months. Your participation will consist of completing a baseline survey and telephone interviews at 3 and 6 months after your enrollment to ask questions about your ability to perform common everyday activities, medications you are taking, medical care that you have received, symptoms you are having related to your stroke, and how your feeling.


Clinical Study Identifier: s16-00552
ClinicalTrials.gov Identifier: NCTs16-00552


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.